|
|
|
Insider
Information: |
Sanofi-Aventis |
Relationship: |
10% Owner |
City: |
Paris |
State: |
I0 |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
11 |
|
Direct
Shares |
75,668,031 |
|
Indirect Shares
|
26,048,661 |
|
|
Direct
Value |
$2,826,957,638 |
|
|
Indirect Value
|
$1,869,919,512 |
|
|
Total
Shares |
101,716,692 |
|
|
Total
Value |
$4,696,877,150 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
5
|
Stock
price went up :
|
0
|
2
|
Stock
price went down : |
1
|
3
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
Percentage
Gain/Loss : |
-17.8%
|
-3.6%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Regulus Therapeutics Inc. |
RGLS |
10% Owner |
|
0 |
2014-02-04 |
5,053,779 |
Premium* |
|
Humanigen Inc |
HGEN |
Former 10% owner |
2013-01-31 |
0 |
2013-01-31 |
579,030 |
Premium* |
|
Glycomimetics Inc |
GLYC |
10% Owner |
|
0 |
2013-11-06 |
1,193,625 |
Premium* |
|
Regeneron Pharmaceuticals Inc |
REGN |
|
2020-05-29 |
0 |
2020-06-09 |
279,766 |
Premium* |
|
Alnylam Pharmaceuticals Inc |
ALNY |
10% Owner |
|
0 |
2017-05-31 |
10,554,134 |
Premium* |
|
Scynexis Inc |
SCYX |
10% Owner |
|
0 |
2014-05-07 |
1,677,057 |
Premium* |
|
Voyager Therapeutics, Inc. |
VYGR |
Former 10% owner |
2015-11-10 |
0 |
2015-11-16 |
2,477,941 |
Premium* |
|
Fulcrum Therapeutics, Inc. |
FULC |
10% Owner |
2019-07-22 |
0 |
2019-07-22 |
558,035 |
Premium* |
|
Inozyme Pharma, Inc. |
INZY |
10% Owner |
2020-07-28 |
0 |
2020-07-28 |
520,125 |
Premium* |
|
Icosavax, Inc. |
ICVX |
10% Owner |
2021-08-02 |
0 |
2021-08-02 |
3,155,169 |
Premium* |
|
Translate Bio, Inc. |
TBIO |
10% Owner |
2021-09-14 |
75,668,031 |
2021-09-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
TBIO |
Translate Bio, Inc. |
10% Owner |
|
2021-09-14 |
4 |
B |
$38.00 |
$2,147,483,647 |
D/D |
71,983,597 |
75,668,031 |
2.45 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
|
|
2020-05-29 |
4 |
S |
$509.85 |
$2,147,483,647 |
D/D |
(20,421,899) |
0 |
0 |
% |
|
ICVX |
Icosavax, Inc. |
10% Owner |
|
2021-08-02 |
4 |
A |
$0.00 |
$0 |
I/I |
3,088,502 |
3,088,502 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
|
|
2020-05-29 |
4 |
S |
$509.85 |
$1,223,411,587 |
I/I |
(2,399,552) |
400,000 |
0 |
% |
|
VYGR |
Voyager Therapeutics, Inc... |
Former 10% owner |
|
2015-11-10 |
4 |
A |
$0.00 |
$0 |
I/I |
2,352,941 |
2,352,941 |
0 |
- |
|
RGLS |
Regulus Therapeutics Inc. |
10% Owner |
|
2014-02-04 |
4 |
B |
$7.67 |
$9,999,993 |
I/I |
1,303,780 |
5,053,779 |
1.5 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
10% Owner |
|
2015-01-26 |
4 |
B |
$95.00 |
$61,507,560 |
I/I |
647,448 |
9,954,485 |
1.5 |
- |
|
FULC |
Fulcrum Therapeutics, Inc... |
10% Owner |
|
2019-07-22 |
4 |
A |
$0.00 |
$0 |
I/I |
464,285 |
464,285 |
0 |
- |
|
INZY |
Inozyme Pharma, Inc. |
10% Owner |
|
2020-07-28 |
4 |
A |
$0.00 |
$0 |
I/I |
438,875 |
438,875 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
10% Owner |
|
2014-03-25 |
4 |
B |
$66.88 |
$23,036,682 |
I/I |
344,448 |
9,110,786 |
1.5 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
10% Owner |
|
2014-03-24 |
4 |
B |
$299.01 |
$94,511,734 |
I/I |
306,945 |
18,790,310 |
1.5 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
10% Owner |
|
2014-03-27 |
4 |
B |
$302.96 |
$95,463,963 |
I/I |
306,945 |
19,711,145 |
1.5 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
10% Owner |
|
2014-03-28 |
4 |
B |
$300.28 |
$94,149,583 |
I/I |
306,945 |
20,018,090 |
1.5 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
10% Owner |
|
2014-03-21 |
4 |
B |
$313.12 |
$98,008,222 |
I/I |
305,115 |
18,483,365 |
1.5 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
10% Owner |
|
2017-05-31 |
4 |
B |
$71.87 |
$21,381,397 |
I/I |
297,501 |
10,554,134 |
1.5 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
10% Owner |
|
2014-07-07 |
4 |
AB |
$311.17 |
$80,320,795 |
I/I |
256,700 |
21,252,741 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
10% Owner |
|
2014-03-03 |
4 |
B |
$328.00 |
$85,070,118 |
I/I |
251,594 |
17,001,214 |
1.5 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
10% Owner |
|
2014-03-07 |
4 |
B |
$327.77 |
$80,405,733 |
I/I |
241,818 |
17,393,309 |
1.5 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
10% Owner |
|
2014-03-12 |
4 |
B |
$325.40 |
$73,964,412 |
I/I |
220,995 |
17,994,836 |
1.5 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
10% Owner |
|
2014-06-30 |
4 |
AB |
$275.68 |
$60,010,479 |
I/I |
212,400 |
20,471,241 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
10% Owner |
|
2014-07-01 |
4 |
AB |
$285.89 |
$63,761,421 |
I/I |
212,400 |
20,683,641 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
10% Owner |
|
2014-07-02 |
4 |
AB |
$298.91 |
$65,259,552 |
I/I |
212,400 |
20,896,041 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
10% Owner |
|
2014-02-05 |
4 |
B |
$274.64 |
$58,367,107 |
I/I |
206,978 |
16,581,109 |
1.5 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
10% Owner |
|
2016-02-01 |
4 |
B |
$69.75 |
$14,300,843 |
I/I |
205,030 |
10,256,633 |
1.5 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
10% Owner |
|
2014-03-10 |
4 |
B |
$325.34 |
$65,687,435 |
I/I |
199,822 |
17,593,131 |
1.5 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|